ENTITY
Celltrion Healthcare

Celltrion Healthcare (091990 KS)

216
Analysis
Health Care • South Korea
Celltrion Healthcare Co.,Ltd develops and manufactures pharmaceutical biologics and chemically synthesized drugs. The Company specializes in the development of drugs for breast cancer, arthritis, leukemia, psoriasis, human rabies prevention, and influenza. Celltrion Healthcare markets its products to customers internationally.
more
bullish•Wuxi Biologics
•16 Jul 2020 10:21

Wuxi Biologics - Recap/Learnings from past Placements

Wuxi Biologics (Cayman) Inc (2269 HK) has seen a total of ten placements since listing in Jun 2017. We've covered all of the deals. Given that the...

Logo
630 Views
Share
•11 Jul 2020 14:37

Asia Short Interest Weekly - PingAn, WuXi Bio, Meituan, SMIC, Fast Retail, Sumitomo, Yageo, Genius

The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...

Logo
478 Views
Share
•06 Jul 2020 19:30

Celltrion Healthcare: Block Deal Sale by One Equity Partners (Time to Turn Bearish)

It was announced after the market close today that One Equity Partners will sell 3.15 million shares of Celltrion Healthcare (091990 KS) shares in...

Logo
463 Views
Share
•06 Jul 2020 16:40

Celltrion Healthcare Placement: Clean up Trade for One Equity Partner

One Equity Partners is looking to sell 3.16 m shares in Celltrion Healthcare (091990 KS). This is a clean up trade by the shareholder and happens...

Logo
493 Views
Share
•06 Jul 2020 05:04

Celltrion Pair Trade: Healthcare Being Pushed Out a Little Too Extreme

The Celltrion duo is now at -1.6σ on a 20D MA. It is virtually the widest diversion we see in a month.The current price ratio is 0.35, which is a...

Logo
448 Views
Share
x